Public Market Listing
1672HKEX
Live quotes, historical charts, and market capitalization for Ascletis Pharma are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
3Phase 3 / Filed
1Phase 1–2 / Early
6Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | GLP-1 receptorSmall molecule | Obesity | |
| Phase 3 | Fatty acid synthase (FASN) · FASNSmall molecule | MASH / NASHMetabolic Dysfunction-Associated Steatohepatitis | |
| Phase 3 | PD-L1Monoclonal antibody | HIVNon-Small Cell Lung CancerChronic Hepatitis B | |
| Phase 1 | Thyroid hormone receptor-betaSmall molecule | Obesity |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.